Search Results
Results found for "Lauren T May"
- 📰 GPCR Weekly News, September 4 to 10, 2023
2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10, 2024 | AACR Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 | ASPET 2024 May 27 - 29, 2024 | SLAS
- 📰 GPCR Weekly News, January 15 to 21, 2024
Discovery Chemistry April 4 - 7, 2024 | American Physiology Summit April 5 - 10, 2024 | AACR Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 | ASPET 2024 May 27 - 29, 2024 | SLAS
- 📰 GPCR Weekly News, August 28 to September 3, 2023
2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10, 2024 | AACR Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 | ASPET 2024 May 27 - 29, 2024 | SLAS
- 📰 GPCR Weekly News, February 20 to 26, 2023
Sometimes we may miss publications. (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).
- 📰 GPCR Weekly News, December 18 to 31, 2023
Physiology Summit April 5 - 10, 2024 | AACR Annual Meeting April 22 - 23, 2024 | Endocrine Metabolic GPCRs May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 | ASPET 2024 May 27 - 29, 2024 | SLAS
- Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease
Thus, increased SHH activity due to ciliary dysfunction may be required for the development of pathoetiological Inhibiting overactive SHH signaling may be a potential neuroprotective therapy for sPD."
- 📰 GPCR Weekly News, December 11 to 17, 2023
Physiology Summit April 5 - 10, 2024 | AACR Annual Meeting April 22 - 23, 2024 | Endocrine Metabolic GPCRs May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 | ASPET 2024 May 27 - 29, 2024 | SLAS
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
The same compound may appear inactive in one substrate system, then wildly active in another. neurodegeneration, metabolic disease, and regenerative pharmacology—fields where fine-tuning enzyme behavior may
- 📰 GPCR Weekly News, January 29 to February 4, 2024
Discovery Chemistry April 4 - 7, 2024 | American Physiology Summit April 5 - 10, 2024 | AACR Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 | ASPET 2024 May 27 - 29, 2024 | SLAS
- Platelets in the NETworks interweaving inflammation and thrombosis
Platelet α-granules contain microbicidal proteins, chemokines and growth factors, which upon release may negatively charged DNA within NETs provides a procoagulant surface, and in particular NET-derived proteins may Here, virus infiltration may lead to a cytokine storm that potently activates neutrophils and leads to
- Functional modulation of PTH1R activation and signaling by RAMP2
However, it is unknown whether and how RAMP proteins may affect PTH1R function. These data uncover a critical role of RAMPs in the activation and signaling of a GPCR that may provide
- The Hidden Cost of Unclear Biotech Positioning
Improving slides or polishing the pitch may reduce surface-level friction, but the core problem remains This puts the burden of synthesis on the listener , who may not share the same context or priorities.
- Domain Therapeutics Raises $42m Series A Financing
May 2022 "Published: May 10, 2022 To accelerate clinical development of its best-in-class and first-in-class
- 📰 GPCR Weekly News, October 30 to November 4, 2023
2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10, 2024 | AACR Annual Meeting May 13 - 17, 2024 | 20th Annual PEGS Boston Summit May 16 - 19, 2024 | ASPET 2024 May 27 - 29, 2024 | SLAS
- 📰 GPCR Weekly News, January 23 to 29, 2023
(May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).
- GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation
increased under acute inflammatory stimuli such as lipopolysaccharide (LPS) and TNFα suggests that it may define a unique role of GPR84 in innate immune cells and intestinal inflammation, and suggest that GPR84 may
- 📰 GPCR Weekly News, January 16 to 22, 2023
(May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development important new data at both LSX World Congress and TIDES USA 2022 conference, taking place this week – May
- 📰 GPCR Weekly News, March 27 to April 4, 2023
GPCR Symposium on GPCR Activation and Signaling held on May 19th, 2023. (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).
- 📰 GPCR Weekly News, March 20 to 26, 2023
(May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).
- 📰 GPCR Weekly News, February 6 to 12, 2023
(May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).
- 📰 GPCR Weekly News, March 6 to 12, 2023
(May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
April 24 - 27, 2025 | American Physiology Summit 2025 April 25 - 30, 2025 | AACR Annual Meeting 2025 May 12 - 15, 2025 | PEGS 2025 May 20 - 22, 2025 | SLAS Europe 2025 June 16 - 19, 2025 | BIO International
- Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research
For those curves which did not reach plateau the EC50 was not reported since the data may not be accurate results underscore how the type of assay can yield different results and how critical information may
- PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
We propose that Pc(4-4) may serve as a powerful drug not only toward PAR-expressing tumors but also for Pc(4-4) may become a promising candidate for future therapeutic cancer treatment."
- Cell-Type-Specific Effects of the Ovarian Cancer G-Protein Coupled Receptor (OGR1) on Inflammation..
We then demonstrate that sub-cellular localization and alternative signaling pathways may be responsible Our results suggest that strategies to selectively target OGR1 expression may represent a novel therapeutic
- 📰 GPCR Weekly News, February 27 to March 5, 2023
(May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
May 2022 Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal the development of new gastrointestinal therapeutics Tokyo, Japan, Cambridge, UK and New York, USA – May
- Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
May 2022 "MONTREAL (CANADA) – May 17, 2022 – Inversago Pharma Inc.
- 📰 GPCR Weekly News, March 13 to 19, 2023
(May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).




